Essential tremor. Epidemiology, diagnosis, and treatment. Neurologist 2004;10:250-258.
Sullivan, KL, RA Hauser, and TA Zesiewicz. 2004. “Essential Tremor. Epidemiology, Diagnosis, and Treatment. Neurologist 2004;10:250-258.”. Neurologist.
Search
Search results
356 results found
Double-blinded, placebo-controlled study of entacapone in levodopa-treated patients with Parkinson disease. Archives of neurology, 61(10), 1563.
Olanow, CW, K Kieburtz, M Stern, R Watts, JW Langston, M Guarnieri, RA Hauser, and J Hubble. 2004. “Double-Blinded, Placebo-Controlled Study of Entacapone in Levodopa-Treated Patients With Parkinson Disease. Archives of Neurology, 61(10), 1563.”. Archives of Neurology.
Autonomic nervous system dysfunction in Parkinson’s disease. Curr Treat Options Neurol 2003; 5:149-160.
Zesiewicz, TA, MJ Baker, M Wahba, and RA Hauser. 2003. “Autonomic Nervous System Dysfunction in Parkinson’s Disease. Curr Treat Options Neurol 2003; 5:149-160.”. Curr Treat Options Neurol.
Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson’s disease.
Kase, H, S Aoyama, M Ichimura, K Ikeda, A Ishii, T Kanda, K Koga, and . 2003. “Progress in Pursuit of Therapeutic A2A Antagonists: the Adenosine A2A Receptor Selective Antagonist KW6002: Research and Development Toward a Novel Nondopaminergic Therapy for Parkinson’s Disease.”. Neurology.
Randomized trial of the adenosine A2A receptor antagonist istradefylline in advanced PD. Neurology 2003;61:297-303.
Hauser, RA, JP Hubble, and DD Truong. 2003. “Randomized Trial of the Adenosine A2A Receptor Antagonist Istradefylline in Advanced PD. Neurology 2003;61:297-303.”. Neurology.
Driving safety in Parkinson’s disease. Neurology 2002;59:1787-1788.
Zesiewicz, TA, CR Cimino, AR Malek, N Gardner, PL Leaverton, PB Dunne, and RA Hauser. 2002. “Driving Safety in Parkinson’s Disease. Neurology 2002;59:1787-1788.”. Neurology.
Depression in patients with Parkinson's disease: epidemiology, pathophysiology and treatment options. CNS Drugs 2000;13:227-304.
Zesiewicz, TA, and RA Hauser. 2000. “Depression in Patients With Parkinson’s Disease: Epidemiology, Pathophysiology and Treatment Options. CNS Drugs 2000;13:227-304.”. CNS Drugs.
Sildenafil Citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson's disease. Movement Disorders 2000;15:305-308.
Zesiewicz, TA, M Helal, and RA Hauser. 2000. “Sildenafil Citrate (Viagra) for the Treatment of Erectile Dysfunction in Men With Parkinson’s Disease. Movement Disorders 2000;15:305-308.”. Movement Disorders.
Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology. Proceedings of the National Academy of Sciences of the United States of America. 2000;97:13877-82.
Freeman, TB, F Cicchetti, RA Hauser, TW Deacon, and . 2000. “Transplanted Fetal Striatum in Huntington’s Disease: Phenotypic Development and Lack of Pathology. Proceedings of the National Academy of Sciences of the United States of America. 2000;97:13877-82.”. Proceedings of the National Academy of Sciences of the United States of America. .
Neural transplantation for the treatment of Huntington’s disease. Progress in Brain Research 2000;127:405-411.
Freeman, TB, RA Hauser, PR Sanberg, and S Saporta. 2000. “Neural Transplantation for the Treatment of Huntington’s Disease. Progress in Brain Research 2000;127:405-411.”. Progress in Brain Research .